MESI product impresses in study
A study conducted at the University of Helsinki and Helsinki University Hospital has evaluated the performance of the MESI mTABLET TBI toe pressure photoplethysmography device against a stationary laser Doppler flow meter, the current gold standard for assessing superficial microvessels. The University of Helsinki study shows that the MESI mTABLET TBI demonstrates high concordance with the laser Doppler standard and reliably identifies patients with significant ischaemia.
TBI is particularly important in patient groups such as people with diabetes, where conventional ankle-brachial index (ABI) measurements are unreliable. Despite its clinical benefits, TBI has so far been used mainly in secondary care, which can lead to delays in diagnosis.
These results underscore the importance of portable TBI devices such as the MESI mTABLET TBI for clinical decision-making in primary care. Thanks to its ease of use, high accuracy and patient-friendly design, the device can make an important contribution to improving the care of PAD patients, especially where access to specialised procedures is limited.